These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7235927)

  • 1. [Aspects of liver damage after experimental administration of some drugs. Preliminary note].
    Martines G; Copponi V; Cagnetta G
    Arch Sci Med (Torino); 1980; 137(3):367-86. PubMed ID: 7235927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of drugs on the mitochondrial fraction isolated from the liver].
    Braga PC; Cagnetta G; Copponi V
    Clin Ter; 1981 Mar; 96(5):493-501. PubMed ID: 7285520
    [No Abstract]   [Full Text] [Related]  

  • 3. [Silymarin in pregnancy and during hormonal contraceptive treatment. Blood chemistry and ultrastructural findings in the experimental model].
    Martines G; Piva M; Copponi V; Cagnetta G
    Arch Sci Med (Torino); 1979; 136(3):443-54. PubMed ID: 549550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electronic quantification of experimental hepatic lesions demonstrated by histology (author's transl)].
    Stockinger L; Trost W; Uebel H
    Arch Anat Cytol Pathol; 1976; 24(3):203-9. PubMed ID: 938102
    [No Abstract]   [Full Text] [Related]  

  • 5. [Membrane protectors and silymarin in hepatology therapy].
    Grossi F; Viola F
    Clin Ter; 1981 Jan; 96(1):11-23. PubMed ID: 7016408
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical effects of standardized propolis extract (SPE) and of silymarin on the liver of ethyl alcohol intoxicated rats.
    Giurgea R; Rusu MA; Coprean D; Popescu H; Polinicencu C
    Agressologie; 1987 Sep; 28(8):831-2. PubMed ID: 3425824
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of silymarin on the fatty acid composition of the hepatic lipids of estrogenized chickens].
    Sánchez García JA; Santiago Laguna D
    Arch Farmacol Toxicol; 1981 Apr; 7(1):143-50. PubMed ID: 7325707
    [No Abstract]   [Full Text] [Related]  

  • 8. [The pharmacodynamics of hepatic protectors from the lady's-thistle (Silybum marianum)].
    Rumiantseva ZhN
    Vrach Delo; 1991 May; (5):15-9. PubMed ID: 1866906
    [No Abstract]   [Full Text] [Related]  

  • 9. [DNA synthesis in rat liver after repeated administration of E. coli endotoxin--effect of cortisone, fasting and silymarine (author's transl)].
    Simek J; Cervinková Z; Hegerová J; Dvorácková I; Vodicka I
    Cesk Gastroenterol Vyz; 1978 Jan; 32(1):14-20. PubMed ID: 346239
    [No Abstract]   [Full Text] [Related]  

  • 10. [The antagonistic effect of silybin-dihemisuccinate on disorders of phosphatidyl synthesis in the rat liver].
    Schriewer H; Weinhold F; Stöcker K; Rauen HM
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():309-11. PubMed ID: 1029194
    [No Abstract]   [Full Text] [Related]  

  • 11. [Silymarin in the prevention of hepatic damage by psychopharmacologic drugs. Experimental premises and clinical evaluations].
    Carrescia O; Benelli L; Saraceni F; Braga PC; Cagnetta G; Copponi V
    Clin Ter; 1980 Oct; 95(2):157-64. PubMed ID: 7471652
    [No Abstract]   [Full Text] [Related]  

  • 12. Silybin inhibition of amatoxin uptake in the perfused rat liver.
    Faulstich H; Jahn W; Wieland T
    Arzneimittelforschung; 1980; 30(3):452-4. PubMed ID: 7387753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of silymarin on lipids in the blood and liver in steatosis].
    Ulicná O; Brixová E
    Vnitr Lek; 1985 Jan; 31(1):15-9. PubMed ID: 3969785
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemopreventive effect of silymarin on liver pathology in HBV X protein transgenic mice.
    Wu YF; Fu SL; Kao CH; Yang CW; Lin CH; Hsu MT; Tsai TF
    Cancer Res; 2008 Mar; 68(6):2033-42. PubMed ID: 18339886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihepatotoxic flavonoids.
    Wagner H
    Prog Clin Biol Res; 1986; 213():545-58. PubMed ID: 3520594
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity.
    Chrungoo VJ; Reen RK; Singh K; Singh J
    Indian J Exp Biol; 1997 Mar; 35(3):256-63. PubMed ID: 9332170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The liver and drugs. Blood chemical and ultrastructural findings after experimental administration of 7-cromanol-3-methyl-taxifoline].
    Martines G
    Arch Sci Med (Torino); 1977; 134(2):103-23. PubMed ID: 869698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of silymarin on gluconeogenesis in the liver of rats after damage due to phosmet].
    Ulicná O; Bátora I; Kubalová V; Brixová E
    Bratisl Lek Listy; 1988 Sep; 89(9):678-82. PubMed ID: 3208172
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats.
    Ramakrishnan G; Raghavendran HR; Vinodhkumar R; Devaki T
    Chem Biol Interact; 2006 Jun; 161(2):104-14. PubMed ID: 16643877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of colchicine and silymarin on CCl4-chronic liver damage in rats.
    Favari L; Pérez-Alvarez V
    Arch Med Res; 1997; 28(1):11-7. PubMed ID: 9078581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.